ADIX-HEALTHCARE

Subsidiary Company of ADIX GROUP

 

Medizinisches Cannabis

HOME ABOUT US MEDICAL CANNABIS ADIX GROUP

 About us

What do we stand for?

The undersigned founded SATIVA GmbH & GmbH Co. Überlingen as well as SATIVA GmbH in Schaffhausen Switzerland in 2016. In December 2020 ADIX acquired an industrial property in Thayngen (CH). For Germans and other interested parties, a company seat is offered for rent or purchase in order to be able to use the well-known privileges of Switzerland.

 ADIX-HEALTHCARE GmbH came into being after the share sale of the company shares by the sole shareholder Arthur Müller. He was founder, board member and GmbH managing director of ACA Müller ADAG Pharma AG und GmbH.

On March 1st, 2019 he sold his sole company shares to the Canadian investor FCC (stands for Franchise Cannabis Corp.) for a double-digit million amount. No prohibition of competition was expressly agreed with the investor. Rather, an express agreement to continue to work in the same line of business with ADIX-Pharma GmbH, later converted to ADIX-HEALTHCARE GmbH. ADIX works closely with ACA Pharma GmbH based in Hilzingen.  

In 2017, Müller was one of the first importers to apply for and receive the necessary permits and licenses for the distribution of medical cannabis after the German government approved medical cannabis in 2017.

So far, only cannabis from the OMC Netherlands (Office for medical Cannabis) from the manufacturer Bedrocan has been distributed. Further sources of supply from Portugal and Denmark are in negotiations.

ADIX-HEALTHCARE GmbH is in negotiations with CUREVAC AG in Tübingen and BioNTech SE in Mainz for the storage and distribution of vaccines to vaccine centers and medical practices. ADIX has a range of high-performance freezers and containers that guarantee compliance with the cold chain to the vaccinated patient.

ADIX-HEALTHCARE has a high double-digit million amount as working capital. Further participation in the newly founded ADIX-HEALTHCARE KG is definitely welcome. ADIX is ideally positioned to participate in the billion-dollar corona vaccination business and promises its new limited partners a doubling of the equity capital by December 31st 2021.

Preparations for an IPO, initial public offering or M&A with one of the world's leading cannabis companies are planned. Apart from that, ADIX has got a web shop for the sale of CBD cannabis to end customers and pharmacies for months with ASA Top Cannabis GmbH Berlin, which it founded, and ASA Top-NL in Venlo.

The undersigned founded SATIVA GmbH & Co. Überlingen as well as SATIVA GmbH in Schaffhausen Switzerland in 2016. In December 2020 ADIX acquired an industrial property in Thayngen (CH). For Germans and other interested parties, a company headquarters are offered for rent or purchase in order to be able to use the well-known privileges of Switzerland.

With these affiliated companies, ADIX will revive the PRIVATE PLACEMENT November 2016 business project with old and new partners.

Investment, Depot and Wikifolio

After the inflow of several million, ADIX did not leave the amounts on its bank accounts without interest or against negative interest, but instead established a department of stock exchange trading within ADIX-HEALTHCARE GmbH. Since January 2020, this branch of stock exchange trading in stocks in ETFs funds and other securities investments has developed splendidly. The ADIX had and has unique, secret and successful algorithms for stock exchange trades, which are advantageous for this branch of business, including investments in physical gold, ETF, certificates, investments in gold manufacturers such as Barack-Gold, etc.

The success of ADIX is based on many years of know-how in pharmaceuticals and stock exchange trading. Since January 2020, ADIX has posted profit taking of € 1.2 million. In addition, 6 million € invested with a performance of 20%. With the usual valuation according to the P / E ratio (price-earnings-loss) of 15 times, Adix would already be worth 18 million €.

Terms & Conditions Data Protectionction Imprint